Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Abemaciclib

02 1Abrocitinib

03 1Acalabrutinib

04 1Alectinib

05 1Allopurinol

06 1Amlodipine Besilate

07 1Avapritinib

08 1Bisoprolol Fumarate

09 1Blarcamesine

10 1Carvedilol

11 1Chlorpromazine Hydrochloride

12 1Clomiphene Citrate

13 1Crotamiton

14 1Dapagliflozin Propanediol

15 1Deucravacitinib

16 1Donepezil Hydrochloride

17 1Duloxetine

18 1Empagliflozin

19 1Entrectinib

20 1Ethacrynic Acid

21 1Etrasimod

22 1Fruquintinib

23 1Ketoprofen

24 1Levocetirizine Dihydrochloride

25 1Levomepromazine Maleate

26 1Methyldopa

27 1Nifedipine

28 1Nitrendipine

29 1Osimertinib

30 1Ozanimod

31 1Palbociclib

32 1Pimavanserin

33 1Promethazine Hydrochloride

34 1Quetiapine Fumarate

35 1Ramipril

36 1Resmetirom

37 1Ribociclib

38 1Rivaroxaban

39 1Sacubitril And Valsartan

40 1Solriamfetol

41 1Tofisopam

42 1Troriluzole

43 1Upadacitinib

44 1Venetoclax

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countries with its APIs and finished products. Egis focuses on cardiovascular and central nervous system diseases, with offerings in diabetology, dermatology, and ...
Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countries with its APIs and finished products. Egis focuses on cardiovascular and central nervous system diseases, with offerings in diabetology, dermatology, and wound care. Its R&D emphasizes high-quality, value-added branded generics, and since 2023, Egis also provides CDMO and CMO services. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Egis Pharmaceuticals

01

Egis Pharmaceuticals PLC

Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countries with its APIs and finished products. Egis focuses on cardiovascular and central nervous system diseases, with offerings in diabetology, dermatology, and wound care. Its R&D emphasizes high-quality, value-added branded generics, and since 2023, Egis also provides CDMO and CMO services. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

About the Company : Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countri...

Egis Pharmaceuticals
Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countries with its APIs and finished products. Egis focuses on cardiovascular and central nervous system diseases, with offerings in diabetology, dermatology, and ...
Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countries with its APIs and finished products. Egis focuses on cardiovascular and central nervous system diseases, with offerings in diabetology, dermatology, and wound care. Its R&D emphasizes high-quality, value-added branded generics, and since 2023, Egis also provides CDMO and CMO services. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Egis Pharmaceuticals

02

Egis Pharmaceuticals PLC

Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countries with its APIs and finished products. Egis focuses on cardiovascular and central nervous system diseases, with offerings in diabetology, dermatology, and wound care. Its R&D emphasizes high-quality, value-added branded generics, and since 2023, Egis also provides CDMO and CMO services. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

About the Company : Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countri...

Egis Pharmaceuticals
Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countries with its APIs and finished products. Egis focuses on cardiovascular and central nervous system diseases, with offerings in diabetology, dermatology, and ...
Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countries with its APIs and finished products. Egis focuses on cardiovascular and central nervous system diseases, with offerings in diabetology, dermatology, and wound care. Its R&D emphasizes high-quality, value-added branded generics, and since 2023, Egis also provides CDMO and CMO services. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Egis Pharmaceuticals

03

Egis Pharmaceuticals PLC

Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countries with its APIs and finished products. Egis focuses on cardiovascular and central nervous system diseases, with offerings in diabetology, dermatology, and wound care. Its R&D emphasizes high-quality, value-added branded generics, and since 2023, Egis also provides CDMO and CMO services. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

About the Company : Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countri...

Egis Pharmaceuticals
Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countries with its APIs and finished products. Egis focuses on cardiovascular and central nervous system diseases, with offerings in diabetology, dermatology, and ...
Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countries with its APIs and finished products. Egis focuses on cardiovascular and central nervous system diseases, with offerings in diabetology, dermatology, and wound care. Its R&D emphasizes high-quality, value-added branded generics, and since 2023, Egis also provides CDMO and CMO services. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Egis Pharmaceuticals

04

Egis Pharmaceuticals PLC

Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countries with its APIs and finished products. Egis focuses on cardiovascular and central nervous system diseases, with offerings in diabetology, dermatology, and wound care. Its R&D emphasizes high-quality, value-added branded generics, and since 2023, Egis also provides CDMO and CMO services. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

About the Company : Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countri...

Egis Pharmaceuticals
Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countries with its APIs and finished products. Egis focuses on cardiovascular and central nervous system diseases, with offerings in diabetology, dermatology, and ...
Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countries with its APIs and finished products. Egis focuses on cardiovascular and central nervous system diseases, with offerings in diabetology, dermatology, and wound care. Its R&D emphasizes high-quality, value-added branded generics, and since 2023, Egis also provides CDMO and CMO services. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Egis Pharmaceuticals

05

Egis Pharmaceuticals PLC

Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countries with its APIs and finished products. Egis focuses on cardiovascular and central nervous system diseases, with offerings in diabetology, dermatology, and wound care. Its R&D emphasizes high-quality, value-added branded generics, and since 2023, Egis also provides CDMO and CMO services. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

About the Company : Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countri...

Egis Pharmaceuticals
Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countries with its APIs and finished products. Egis focuses on cardiovascular and central nervous system diseases, with offerings in diabetology, dermatology, and ...
Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countries with its APIs and finished products. Egis focuses on cardiovascular and central nervous system diseases, with offerings in diabetology, dermatology, and wound care. Its R&D emphasizes high-quality, value-added branded generics, and since 2023, Egis also provides CDMO and CMO services. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Egis Pharmaceuticals

06

Egis Pharmaceuticals PLC

Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countries with its APIs and finished products. Egis focuses on cardiovascular and central nervous system diseases, with offerings in diabetology, dermatology, and wound care. Its R&D emphasizes high-quality, value-added branded generics, and since 2023, Egis also provides CDMO and CMO services. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

About the Company : Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countri...

Egis Pharmaceuticals
Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countries with its APIs and finished products. Egis focuses on cardiovascular and central nervous system diseases, with offerings in diabetology, dermatology, and ...
Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countries with its APIs and finished products. Egis focuses on cardiovascular and central nervous system diseases, with offerings in diabetology, dermatology, and wound care. Its R&D emphasizes high-quality, value-added branded generics, and since 2023, Egis also provides CDMO and CMO services. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Egis Pharmaceuticals

07

Egis Pharmaceuticals PLC

Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countries with its APIs and finished products. Egis focuses on cardiovascular and central nervous system diseases, with offerings in diabetology, dermatology, and wound care. Its R&D emphasizes high-quality, value-added branded generics, and since 2023, Egis also provides CDMO and CMO services. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

About the Company : Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countri...

Egis Pharmaceuticals
Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countries with its APIs and finished products. Egis focuses on cardiovascular and central nervous system diseases, with offerings in diabetology, dermatology, and ...
Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countries with its APIs and finished products. Egis focuses on cardiovascular and central nervous system diseases, with offerings in diabetology, dermatology, and wound care. Its R&D emphasizes high-quality, value-added branded generics, and since 2023, Egis also provides CDMO and CMO services. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Egis Pharmaceuticals

08

Egis Pharmaceuticals PLC

Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countries with its APIs and finished products. Egis focuses on cardiovascular and central nervous system diseases, with offerings in diabetology, dermatology, and wound care. Its R&D emphasizes high-quality, value-added branded generics, and since 2023, Egis also provides CDMO and CMO services. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

About the Company : Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countri...

Egis Pharmaceuticals
Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countries with its APIs and finished products. Egis focuses on cardiovascular and central nervous system diseases, with offerings in diabetology, dermatology, and ...
Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countries with its APIs and finished products. Egis focuses on cardiovascular and central nervous system diseases, with offerings in diabetology, dermatology, and wound care. Its R&D emphasizes high-quality, value-added branded generics, and since 2023, Egis also provides CDMO and CMO services. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Egis Pharmaceuticals

09

Egis Pharmaceuticals PLC

Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countries with its APIs and finished products. Egis focuses on cardiovascular and central nervous system diseases, with offerings in diabetology, dermatology, and wound care. Its R&D emphasizes high-quality, value-added branded generics, and since 2023, Egis also provides CDMO and CMO services. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

About the Company : Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countri...

Egis Pharmaceuticals
Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countries with its APIs and finished products. Egis focuses on cardiovascular and central nervous system diseases, with offerings in diabetology, dermatology, and ...
Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countries with its APIs and finished products. Egis focuses on cardiovascular and central nervous system diseases, with offerings in diabetology, dermatology, and wound care. Its R&D emphasizes high-quality, value-added branded generics, and since 2023, Egis also provides CDMO and CMO services. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Egis Pharmaceuticals

10

Egis Pharmaceuticals PLC

Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countries with its APIs and finished products. Egis focuses on cardiovascular and central nervous system diseases, with offerings in diabetology, dermatology, and wound care. Its R&D emphasizes high-quality, value-added branded generics, and since 2023, Egis also provides CDMO and CMO services. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

About the Company : Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reaches 100 countri...

Egis Pharmaceuticals
Contact Egis Pharmaceuticals Plc and get a quotation

Egis Pharmaceuticals Plc is a supplier offers 50 products (APIs, Excipients or Intermediates).

Find a price of Promethazine Hydrochloride bulk with DMF, CEP, JDMF offered by Egis Pharmaceuticals Plc

Find a price of Allopurinol bulk with CEP, JDMF offered by Egis Pharmaceuticals Plc

Find a price of Chlorpromazine Hydrochloride bulk with CEP, JDMF offered by Egis Pharmaceuticals Plc

Find a price of Ethacrynic Acid bulk with DMF, CEP offered by Egis Pharmaceuticals Plc

Find a price of Allopurinol bulk with CEP offered by Egis Pharmaceuticals Plc

Find a price of Amlodipine Besylate bulk with CEP offered by Egis Pharmaceuticals Plc

Find a price of Aripiprazole bulk with CEP offered by Egis Pharmaceuticals Plc

Find a price of Bisoprolol Fumarate bulk with CEP offered by Egis Pharmaceuticals Plc

Find a price of Carbidopa bulk with JDMF offered by Egis Pharmaceuticals Plc

Find a price of Carvedilol bulk with CEP offered by Egis Pharmaceuticals Plc

Find a price of Duloxetine Hydrochloride bulk with CEP offered by Egis Pharmaceuticals Plc

Find a price of Levomepromazine Maleate bulk with CEP offered by Egis Pharmaceuticals Plc

Find a price of Methyldopa bulk with CEP offered by Egis Pharmaceuticals Plc

Find a price of Quetiapine Hemifumarate bulk with CEP offered by Egis Pharmaceuticals Plc

Find a price of Ramipril bulk with CEP offered by Egis Pharmaceuticals Plc

Find a price of Tofisopam bulk with JDMF offered by Egis Pharmaceuticals Plc

Find a price of Abemaciclib bulk offered by Egis Pharmaceuticals Plc

Find a price of Abrocitinib bulk offered by Egis Pharmaceuticals Plc

Find a price of Acalabrutinib bulk offered by Egis Pharmaceuticals Plc

Find a price of Alectinib Hydrochloride bulk offered by Egis Pharmaceuticals Plc

Find a price of Avapritinib bulk offered by Egis Pharmaceuticals Plc

Find a price of Blarcamesine bulk offered by Egis Pharmaceuticals Plc

Find a price of Carbadox bulk offered by Egis Pharmaceuticals Plc

Find a price of Clomiphene Citrate bulk offered by Egis Pharmaceuticals Plc

Find a price of Crotamiton bulk offered by Egis Pharmaceuticals Plc

Find a price of Dapagliflozin Propanediol Monohydrate bulk offered by Egis Pharmaceuticals Plc

Find a price of Deucravacitinib bulk offered by Egis Pharmaceuticals Plc

Find a price of Donepezil bulk offered by Egis Pharmaceuticals Plc

Find a price of Empagliflozin bulk offered by Egis Pharmaceuticals Plc

Find a price of Entrectinib bulk offered by Egis Pharmaceuticals Plc

Find a price of Etrasimod bulk offered by Egis Pharmaceuticals Plc

Find a price of Fruquintinib bulk offered by Egis Pharmaceuticals Plc

Find a price of Ketoprofen bulk offered by Egis Pharmaceuticals Plc

Find a price of Levocetirizine Dihydrochloride bulk offered by Egis Pharmaceuticals Plc

Find a price of Methoprene bulk offered by Egis Pharmaceuticals Plc

Find a price of Nifedipine bulk offered by Egis Pharmaceuticals Plc

Find a price of Nitrendipine bulk offered by Egis Pharmaceuticals Plc

Find a price of Osimertinib Mesylate bulk offered by Egis Pharmaceuticals Plc

Find a price of Ozanimod bulk offered by Egis Pharmaceuticals Plc

Find a price of Palbociclib bulk offered by Egis Pharmaceuticals Plc

Find a price of Pimavanserin Tartrate bulk offered by Egis Pharmaceuticals Plc

Find a price of Resmetirom bulk offered by Egis Pharmaceuticals Plc

Find a price of Ribociclib bulk offered by Egis Pharmaceuticals Plc

Find a price of Rivaroxaban bulk offered by Egis Pharmaceuticals Plc

Find a price of Sacubitril-Valsartan bulk offered by Egis Pharmaceuticals Plc

Find a price of Solriamfetol Hydrochloride bulk offered by Egis Pharmaceuticals Plc

Find a price of Tofisopam bulk offered by Egis Pharmaceuticals Plc

Find a price of Troriluzole bulk offered by Egis Pharmaceuticals Plc

Find a price of Upadacitinib bulk offered by Egis Pharmaceuticals Plc

Find a price of Venetoclax bulk offered by Egis Pharmaceuticals Plc